FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002105840> ?p ?o ?g. }

• W2002105840 endingPage "604" @default.
• W2002105840 startingPage "599" @default.
• W2002105840 abstract "To investigate the effectiveness of baclofen for the treatment of tics in children with Tourette syndrome (TS).Baclofen, which contains both gamma-aminobutyric acid (GABA) and phenylethylamine moieties, was suggested in an open-label protocol to be an effective treatment for TS. This is a double-blind, placebo-controlled study to investigate this medication in children with TS.Subjects received, in a randomized sequence, 4-week medication cycles of baclofen (20 mg three times daily) and placebo with a 2-week intervening washout period between the cycles. Outcome measures included the Clinical Global Impression (CGI) scale, and the Yale Global Tic Severity Scale (YGTSS), the latter including subscales for total tics and overall impairment. Measures were assessed at baseline and on days 28, 42, and 70 of the study.Ten children (seven boys and three girls, aged 8 to 14) with TS participated. Nine subjects completed the protocol; one dropped out for psychosocial reasons. No major side effects were reported. The mean change in CGI score (-0.9) after 4 weeks of baclofen treatment as compared with placebo treatment showed a significant improvement (95% CI, -1.7 to -0.1; p = 0.04). All subjects showed some amelioration in total YGTSS score during baclofen treatment. The mean change in total YGTSS score (-14.7) approached significance (95% CI, -30.3 to 0.9; p = 0.06). Examination of differences between baclofen and placebo treatment groups expressed as a percent change from baseline showed that baclofen had a statistically significant effect on both outcome measures. Subscales of the YGTSS showed that the reduction in total tic scores was primarily due to a reduction in the impairment score rather than a decrease in tics.Children with TS may benefit from treatment with baclofen, although improvements may be related to factors other than tics. Larger studies directly comparing baclofen against other tic-suppressing agents are recommended." @default.
• W2002105840 created "2016-06-24" @default.
• W2002105840 creator A5000526754 @default.
• W2002105840 creator A5004792738 @default.
• W2002105840 creator A5015597540 @default.
• W2002105840 creator A5079038813 @default.
• W2002105840 date "2001-03-13" @default.
• W2002105840 modified "2023-09-25" @default.
• W2002105840 title "Baclofen treatment in Tourette syndrome: A double-blind, placebo-controlled, crossover trial" @default.
• W2002105840 cites W1880274770 @default.
• W2002105840 cites W1992407791 @default.
• W2002105840 cites W1995058130 @default.
• W2002105840 cites W2012857322 @default.
• W2002105840 cites W2015540486 @default.
• W2002105840 cites W2019101336 @default.
• W2002105840 cites W2082585241 @default.
• W2002105840 cites W2085084081 @default.
• W2002105840 cites W2088550173 @default.
• W2002105840 cites W2105465219 @default.
• W2002105840 cites W2109789351 @default.
• W2002105840 cites W2118773283 @default.
• W2002105840 cites W2119615820 @default.
• W2002105840 cites W2134766199 @default.
• W2002105840 cites W2139569028 @default.
• W2002105840 cites W2139693994 @default.
• W2002105840 cites W2149629624 @default.
• W2002105840 cites W2163634461 @default.
• W2002105840 cites W2312758785 @default.
• W2002105840 cites W51125588 @default.
• W2002105840 cites W59487928 @default.
• W2002105840 cites W99842634 @default.
• W2002105840 doi "https://doi.org/10.1212/wnl.56.5.599" @default.
• W2002105840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11245709" @default.
• W2002105840 hasPublicationYear "2001" @default.
• W2002105840 type Work @default.
• W2002105840 sameAs 2002105840 @default.
• W2002105840 citedByCount "123" @default.
• W2002105840 countsByYear W20021058402012 @default.
• W2002105840 countsByYear W20021058402013 @default.
• W2002105840 countsByYear W20021058402014 @default.
• W2002105840 countsByYear W20021058402015 @default.
• W2002105840 countsByYear W20021058402016 @default.
• W2002105840 countsByYear W20021058402017 @default.
• W2002105840 countsByYear W20021058402018 @default.
• W2002105840 countsByYear W20021058402019 @default.
• W2002105840 countsByYear W20021058402020 @default.
• W2002105840 countsByYear W20021058402021 @default.
• W2002105840 countsByYear W20021058402022 @default.
• W2002105840 countsByYear W20021058402023 @default.
• W2002105840 crossrefType "journal-article" @default.
• W2002105840 hasAuthorship W2002105840A5000526754 @default.
• W2002105840 hasAuthorship W2002105840A5004792738 @default.
• W2002105840 hasAuthorship W2002105840A5015597540 @default.
• W2002105840 hasAuthorship W2002105840A5079038813 @default.
• W2002105840 hasConcept C118552586 @default.
• W2002105840 hasConcept C126322002 @default.
• W2002105840 hasConcept C142724271 @default.
• W2002105840 hasConcept C15744967 @default.
• W2002105840 hasConcept C168563851 @default.
• W2002105840 hasConcept C170493617 @default.
• W2002105840 hasConcept C204787440 @default.
• W2002105840 hasConcept C27081682 @default.
• W2002105840 hasConcept C2776000289 @default.
• W2002105840 hasConcept C2777026814 @default.
• W2002105840 hasConcept C2777200579 @default.
• W2002105840 hasConcept C2778938600 @default.
• W2002105840 hasConcept C2781201050 @default.
• W2002105840 hasConcept C42219234 @default.
• W2002105840 hasConcept C71924100 @default.
• W2002105840 hasConcept C87813604 @default.
• W2002105840 hasConceptScore W2002105840C118552586 @default.
• W2002105840 hasConceptScore W2002105840C126322002 @default.
• W2002105840 hasConceptScore W2002105840C142724271 @default.
• W2002105840 hasConceptScore W2002105840C15744967 @default.
• W2002105840 hasConceptScore W2002105840C168563851 @default.
• W2002105840 hasConceptScore W2002105840C170493617 @default.
• W2002105840 hasConceptScore W2002105840C204787440 @default.
• W2002105840 hasConceptScore W2002105840C27081682 @default.
• W2002105840 hasConceptScore W2002105840C2776000289 @default.
• W2002105840 hasConceptScore W2002105840C2777026814 @default.
• W2002105840 hasConceptScore W2002105840C2777200579 @default.
• W2002105840 hasConceptScore W2002105840C2778938600 @default.
• W2002105840 hasConceptScore W2002105840C2781201050 @default.
• W2002105840 hasConceptScore W2002105840C42219234 @default.
• W2002105840 hasConceptScore W2002105840C71924100 @default.
• W2002105840 hasConceptScore W2002105840C87813604 @default.
• W2002105840 hasIssue "5" @default.
• W2002105840 hasLocation W20021058401 @default.
• W2002105840 hasLocation W20021058402 @default.
• W2002105840 hasOpenAccess W2002105840 @default.
• W2002105840 hasPrimaryLocation W20021058401 @default.
• W2002105840 hasRelatedWork W1979032248 @default.
• W2002105840 hasRelatedWork W2002105840 @default.
• W2002105840 hasRelatedWork W2086523228 @default.
• W2002105840 hasRelatedWork W2153846694 @default.
• W2002105840 hasRelatedWork W2339450775 @default.
• W2002105840 hasRelatedWork W2562054892 @default.
• W2002105840 hasRelatedWork W3206336443 @default.

• next